CC Private Equity Partners

CC Private Equity Partners was a private equity and venture capital firm headquartered in Hamilton, Bermuda, with a significant operational branch in Zurich, Switzerland. The firm specialized in growth-stage investments and buyouts, focusing on sectors such as biotechnology, clean technology, and advanced materials. Its life science portfolio included notable companies such as Pevion Biotech, a Swiss vaccine developer, and Neurotune AG, a biopharmaceutical company targeting neurological and muscular disorders. The firm was active during the mid-2000s and early 2010s but has since entered liquidation, with its Bermuda registration officially struck off in late 2023.